A precise oral glucose loading 18F-FDG PET myocardial metabolic imaging protocol in coronary artery disease patients complicated by diabetes mellitus: an exploratory prospective cohort study
Open Access
- 10 July 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1899226
Abstract
Objectives: We evaluated the feasibility of using a precise oral glucose loading combined with subcutaneous insulin administration protocol for 18 F-FDG PET myocardial metabolic imaging in patients with coronary artery disease (CAD) complicated by diabetes mellitus (DM). Methods: 179 consecutive CAD patients complicated by DM were enrolled. Oral glucose was given at variable doses based on baseline blood glucose, and subcutaneous insulin was injected at adjusted doses according to post-load glucose levels before FDG injection. SPECT myocardial perfusion imaging and PET myocardial metabolic imaging were performed using a one-day protocol. The image quality and adverse reaction data were analyzed. Results: Among 179 patients, FDG image quality was scored as excellent in 57.5%, very good in 31.8%, good in 7.8%, fair in 1.7% and non-diagnostic in 1.1%. When patients were stratified by blood glucose level at time of FDG injection >7.77 mmol/L, 5.55–7.77 mmol/L and 7.77 mmol/L had significantly lower odds of excellent image quality ( p = 0.021) than those with 5.55–7.77 mmol/L or p = 0.262). 47 patients (26.3%) exhibited completely viable myocardium, 89 patients (49.7%) had partially viable myocardium, and 43 patients (24.0%) showed nonviable myocardium. None of the patients had severe adverse reactions. Conclusion: The precise oral glucose loading protocol prior to 18 F-FDG injection is feasible for clinical application.Keywords
This publication has 26 references indexed in Scilit:
- An Optimized Fast Track Protocol to Enhance the Image Quality of 18F-FDG PET Myocardial Viability Imaging in Diabetic CAD Patients: A Randomized Controlled TrialMolecular Imaging and Biology, 2026
- Feasibility and application of trimetazidine in 18F-FDG PET myocardial metabolic imaging of diabetic mellitus patients with severe coronary artery disease: A prospective, self-controlled studyJournal of Nuclear Cardiology, 2022
- Intravenous insulin injection supplemented with subsequent milk consumption is a safer formulation for cardiac viability 18F-FDG imagingJournal of Nuclear Cardiology, 2022
- Intravenous regular insulin is an efficient and safe procedure for obtaining high-quality cardiac 18F-FDG PET images: an open-label, single-center, randomized controlled prospective trialJournal of Nuclear Cardiology, 2020
- Preserved myocardial viability in patients with chronic total occlusion of a single coronary arteryJournal of Nuclear Cardiology, 2020
- Myocardial viability with chronic total occlusion assessed by hybrid positron emission tomography/magnetic resonance imagingJournal of Nuclear Cardiology, 2020
- The Current Role of Viability Imaging to Guide Revascularization and Therapy Decisions in Patients With Heart Failure and Reduced Left Ventricular FunctionCanadian Journal of Cardiology, 2019
- ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology proceduresJournal of Nuclear Cardiology, 2016
- PET myocardial perfusion and metabolism clinical imagingJournal of Nuclear Cardiology, 2009
- The need for standardisation of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischaemic left ventricular dysfunctionEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002